<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药渡 | wechat-feeds</title><link>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</link><description>药渡以自有药物大数据为依托，对上市及临床在研药物、药物研究进展和重要药物市场商业动态作出信息整合分析，传递药物创新一手资讯</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 27 Feb 2021 11:43:17 +0800</pubDate><image><url>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</url><title>药渡 | wechat-feeds</title><link>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>全球首款化疗骨髓保护新药Trilaciclib，不一样的CDK4/6抑制剂</title><link>https://mp.weixin.qq.com/s/IIBPhPOBB1F2_T8FVINcfg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu3doRFGPzmSw0G4FG446rop1QFpzxxkgfiaMpG4tUeICvRkhWBzeDYkV310cl3vVbThLOWGwkBhv8Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药渡出品]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:49:04 +0800</pubDate></item><item><title>甘莱宣布THR-β激动剂ASC41 NASH适应症美国临床试验申请获批及全球开发计划的启动</title><link>https://mp.weixin.qq.com/s/3-FN3m6gDUqZnrjvXETpKg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu3doRFGPzmSw0G4FG446rop7Vib31ysKKN9UawcRMsfILrk3JBdOXjtadrsSKc5NYdyD8Yc2ECtthw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>歌礼]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:49:04 +0800</pubDate></item><item><title>NEJM：重磅！一种新型的口服组合性疗法有望根治子宫肌瘤！</title><link>https://mp.weixin.qq.com/s/rKoPWdlLem-rgePN12wQTw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu3doRFGPzmSw0G4FG446ropnZ6B8LCXibTwzfnRMx7bJxrVcHZJNToUibNrXgCzvAmZnTTI4gLMoO6A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>目前治疗子宫肌瘤除了手术外几乎没有其它更好的治疗选择。]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:49:04 +0800</pubDate></item><item><title>Cytiva赋能生物制药系列课程第2课：加速新型抗体药物开发策略</title><link>https://mp.weixin.qq.com/s/mORnCHGz6fSVfYXcb0SuPw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu0aMOyicsgDX1DR1hBL5ibIicHQb5AMh5SsTzJPfeF7MByRiarh7QQct6Iial770pahUISO8WYrHMhYgag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>3月3日晚19:30，直播间不见不散！]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:49:04 +0800</pubDate></item><item><title>药研论坛｜药品注册现场核查及M4注册申报文件撰写与递交专题培训</title><link>https://mp.weixin.qq.com/s/l8X6puEL9MmklhSKGoGjPA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu3doRFGPzmSw0G4FG446ropzBbFLRw1BErh0OnfickZuTaVDBFM9BxUG2TZj5Auic2j4FQZAesyyT4g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年3月20~21（周六日）地点：南京曙光国际大酒店]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:49:04 +0800</pubDate></item><item><title>好书推荐 |《基于脂质的纳米载体在药物递送和诊断中的应用》</title><link>https://mp.weixin.qq.com/s/yu2gjcHhqGjGZYIfy9GD-w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu2ybibibHakweTZAS9jaC1Z1TklbyHZy2oJaPbfRpVOl68Tia1iawzcKAnzZTQynWYviar7AoBDmPT6Wqg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药渡精选图书]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:49:04 +0800</pubDate></item><item><title>浅谈：从药理&amp;毒理&amp;警示结构，理解药物的基因毒问题！</title><link>https://mp.weixin.qq.com/s/YuoyETBQDERuCgO3uNJ8sA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu2c6weemPW8AsibVbdZHkr8sOzGj5TTe0ebU1AeWVgRj81JAicQkFv7L8r5RiasNjPe2QibKb5MmA8dOQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>基因毒问题，最为根本的还是安全性问题，而一个物质是否安全、是否存在基因毒，要靠试验和数据来证明。]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:25:32 +0800</pubDate></item><item><title>熙宁小课 | 基于流式细胞术的大分子药物受体占位研究</title><link>https://mp.weixin.qq.com/s/aCEmhxyoHwQIkidUZ0UFsQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu2c6weemPW8AsibVbdZHkr8swO054mhvdlodZjjszUsI5eoYYwVznicWEuYIGbdwPGEFmCDoj8ZvXJA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>流式细胞术是一种非常成熟的技术，在临床前和临床过程中有广泛的应用并发挥了非常重要的作用。]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:25:32 +0800</pubDate></item><item><title>我国原创I类中药新药阿可拉定治疗晚期肝癌III期临床结果将亮相ASCO</title><link>https://mp.weixin.qq.com/s/gCwdcVw8uEjZId4r9Pu47g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu2c6weemPW8AsibVbdZHkr8sPL6wZgxbMGa1NmVuuQsH3bichu5whqAngHk9qeYsaiaiaHHEcTBiak6Mzg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>盛诺基医药二月初已提交Pre-NDA申请，拟于近期提出新药上市申请。]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:25:32 +0800</pubDate></item><item><title>Cytiva赋能生物制药系列课程第2课：加速新型抗体药物开发策略</title><link>https://mp.weixin.qq.com/s/Cu6wqB03T_CcuEJfQH9pvA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu0aMOyicsgDX1DR1hBL5ibIicHQb5AMh5SsTzJPfeF7MByRiarh7QQct6Iial770pahUISO8WYrHMhYgag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>3月3日晚19:30，直播间不见不散！]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:25:32 +0800</pubDate></item><item><title>报名通道火热开启！2021亚洲制药产业大会邀您6月上海见！</title><link>https://mp.weixin.qq.com/s/SPguqndnU6o_j0R-VGdfRA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu2c6weemPW8AsibVbdZHkr8s8ibv0WIQ4w9ZicSbchAshAvBaxSLWNb6icZmCsIqOy3hIMkzmya2MSyoQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>带您回顾上届重磅发言嘉宾！]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:25:32 +0800</pubDate></item><item><title>好书推荐 | 药明康德经典译丛——《药物代谢动力学技术在药物设计和开发中的应用》</title><link>https://mp.weixin.qq.com/s/awkg9EQPsKIC7L4Pj8yYdw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu3KXqUe5SfMict8wcPwlvicvwpNX3IUgiaAbhOJVicUlmficY1Bb6mm9vzGIZaxL2jGQ2Ny6juM04TGv3A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本书翻译工作主要由药明康德新药开发有限公司测试事业部下属药性评价部（DMPK）科研团队完成。]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:25:32 +0800</pubDate></item><item><title>药渡招聘 | 医药学术总监</title><link>https://mp.weixin.qq.com/s/qGgRAm1sfRGyro2uwHhDWg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu2SbXz3EPfLVa6wFpYoiapu5kz7Ffv8Bzvj5ATrAshUjEiamn7mXUFtglootBqicP9jZOX7k9x4HuzTA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药渡欢迎每一位致力于医药数据的有志之士！]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:25:32 +0800</pubDate></item><item><title>优势片段杂交策略在药物研发中的应用</title><link>https://mp.weixin.qq.com/s/ZhgYunCBSsLAj5ovI6qZgQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu0aMOyicsgDX1DR1hBL5ibIicHflf3Q0nLEw2ibmxrAyk69JFVsXzKtmegmHDibL6MiciaiaOtFel7pSibbTrA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>其具有思路清晰、研发时间短及成本低等优势，但是在实际操作时需要借助一部分外界的力量……]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:09:14 +0800</pubDate></item><item><title>Cytiva赋能生物制药系列课程第2课：加速新型抗体药物开发策略</title><link>https://mp.weixin.qq.com/s/z8ty2fFDNReAgYojx6Y0iQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu0aMOyicsgDX1DR1hBL5ibIicHQb5AMh5SsTzJPfeF7MByRiarh7QQct6Iial770pahUISO8WYrHMhYgag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>3月3日晚19:30，直播间不见不散！]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:09:14 +0800</pubDate></item><item><title>新药频出，胆管癌靶向药Futibatinib控制率超80%，前景光明</title><link>https://mp.weixin.qq.com/s/94UJ8xWXgF8woIg6CZPPqw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu0aMOyicsgDX1DR1hBL5ibIicHcKriaZ8xUWAyZ3eZ3AJZXjUIrrjRdZAPFvLmJuTle1kwXdJ4mKXTIjA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>对具有FGFR2基因融合或重排的难治性肝内胆管细胞癌患者提供了有意义的临床益处。]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:09:14 +0800</pubDate></item><item><title>议程公开|60+生物药企领袖聚首申城，研发动态、成果展示、合作案例，你想了解的单抗/双抗/ADC热点尽在BIT 2021！</title><link>https://mp.weixin.qq.com/s/rLYYSkqmqc0Fa1BOtobPFg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu0aMOyicsgDX1DR1hBL5ibIicHIibx3LglwVthtGddQAibTxibxL5WTSejDSesF1sWU3BwXLDnBiavIf8lBg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>群星璀璨]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:09:14 +0800</pubDate></item><item><title>好书推荐 | 药明康德经典译丛：有机人名反应——机理及合成应用（原书第五版）</title><link>https://mp.weixin.qq.com/s/0sPJJMEbBUYGs4qFuSV48g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu1s9o0sr7BcPT4kmGOVYDrcYoVmNgc8Oia5W0jvkHL6Xs3do8dztBEWcyfGEVT9dIKhPIRe5RxFzXw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>有机人名反应——机理及合成应用（原书第五版）正式出版啦！]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:09:14 +0800</pubDate></item><item><title>药渡招聘 | 咨询合伙人</title><link>https://mp.weixin.qq.com/s/Jd5dxId10fd4sHtomxRMBw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu2SbXz3EPfLVa6wFpYoiapu5kz7Ffv8Bzvj5ATrAshUjEiamn7mXUFtglootBqicP9jZOX7k9x4HuzTA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药渡欢迎每一位致力于医药数据的有志之士！]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:09:14 +0800</pubDate></item><item><title>创新药的研发——靶点筛选及研发平台的搭建是关键</title><link>https://mp.weixin.qq.com/s/X-pWHwnQIlWSmpzspz7ndw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/dRGVUcLiaOu25b5VA7AnG5icdjkm3SVrnf1wGbzA1yJyxErIDgApYRGVNNCKHRWQ6L83NGZn4ianGRkjWrb8ptkWg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Tue, 23 Feb 2021 18:10:05 +0800</pubDate></item></channel></rss>